Stereoselective Block of hERG Channel by (S)‐Methadone and QT Interval Prolongation in CYP2B6 Slow Metabolizers
暂无分享,去创建一个
P. Carrupt | J. Schläpfer | J. Rougier | C. Eap | L. Sintra Grilo | J. Déglon | S. Crettol | J. Besson | M. Croquette-Krokar | Hugues Abriel
[1] C. Katlama,et al. Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice. , 2009, Critical reviews in oncology/hematology.
[2] R. Walsky,et al. Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6 , 2006, Journal of clinical pharmacology.
[3] C. Eap,et al. ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment , 2006, Clinical pharmacology and therapeutics.
[4] D. Shah,et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. , 2006, Archives of internal medicine.
[5] R. D. Bruce,et al. Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications: Implications and Management for Clinical Practice , 2006, Journal of acquired immune deficiency syndromes.
[6] C. Eap,et al. Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment , 2005, Clinical pharmacology and therapeutics.
[7] M. Eichelbaum,et al. Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz , 2005, Pharmacogenetics and genomics.
[8] R. Woosley,et al. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system , 2005, Pharmacoepidemiology and drug safety.
[9] Nicole Schmitt,et al. Local Anesthetic Interaction with Human Ether-a-go-go–related Gene (HERG) Channels: Role of Aromatic Amino Acids Y652 and F656 , 2005, Anesthesiology.
[10] C. January,et al. Intragenic Suppression of Trafficking-Defective KCNH2 Channels Associated with Long QT Syndrome , 2005, Molecular Pharmacology.
[11] C. Sticherling,et al. Methadone-induced Torsade de pointes tachycardias. , 2005, Swiss medical weekly.
[12] P. Tarantino,et al. Effect of trazodone on hERG channel current and QT-interval. , 2005, European journal of pharmacology.
[13] Michael C Sanguinetti,et al. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. , 2005, Trends in pharmacological sciences.
[14] T. Buclin,et al. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy. , 2004, Swiss medical weekly.
[15] E. Kharasch,et al. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone , 2004, Clinical pharmacology and therapeutics.
[16] P. Dayer,et al. QT interval prolongation in patients on methadone with concomitant drugs. , 2004, Journal of clinical psychopharmacology.
[17] J. Gerber,et al. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. , 2004, Chirality.
[18] M. Eichelbaum,et al. CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real‐rime PCR , 2003, Human mutation.
[19] F. Segura,et al. QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone. , 2003, The American journal of cardiology.
[20] H. Thaler,et al. QTc interval prolongation associated with intravenous methadone , 2003, Pain.
[21] Evan Mokwe,et al. Torsade de pointes due to methadone. , 2003, Annals of internal medicine.
[22] P. Walker,et al. High dose methadone and ventricular arrhythmias: a report of three cases , 2003, Pain.
[23] D. De Bels,et al. Torsades de pointes due to methadone. , 2003, Annals of internal medicine.
[24] I. Anguera,et al. Torsade de pointes due to methadone. , 2003, Annals of internal medicine.
[25] J. Tamargo,et al. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block , 2002, British journal of pharmacology.
[26] A. Katchman,et al. Influence of Opioid Agonists on Cardiac HumanEther-a-go-go-related Gene K+ Currents , 2002, Journal of Pharmacology and Experimental Therapeutics.
[27] P. Mehler,et al. Torsade de Pointes Associated with Very-High-Dose Methadone , 2002, Annals of Internal Medicine.
[28] T. Buclin,et al. Interindividual Variability of the Clinical Pharmacokinetics of Methadone , 2002, Clinical pharmacokinetics.
[29] J. Caldwell. Do single enantiomers have something special to offer? , 2001, Human psychopharmacology.
[30] U. Hofmann,et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. , 2001, Pharmacogenetics.
[31] A. Gorman,et al. The d- and l- isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord , 1997, Neuroscience Letters.
[32] A. Molven,et al. Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 gene , 1996, FEBS letters.
[33] R. Shank,et al. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. , 1995, The Journal of pharmacology and experimental therapeutics.
[34] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[35] P. Krogsgaard‐Larsen,et al. Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord , 1995, Neuroscience Letters.
[36] L. Christrup,et al. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. , 1995, Life sciences.
[37] L. Christrup,et al. Pharmacology letterThe mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine , 1994 .
[38] W. P. Gordon,et al. Seminal excretion, vaginal absorption, distribution and whole blood kinetics of d-methadone in the rabbit. , 1978, The Journal of pharmacology and experimental therapeutics.
[39] H. Sullivan,et al. Urinary metabolites of dl-methadone in maintenance subjects. , 1973, Journal of medicinal chemistry.
[40] R. Bloch,et al. Physiological disposition and metabolism of levo-methadone-1- 3 H in nontolerant and tolerant rats. , 1973, The Journal of pharmacology and experimental therapeutics.
[41] J. Bogdanowicz,et al. REPORT OF THREE CASES. , 1963, American journal of diseases of children.
[42] G. A. Drew. HENS THAT HAVE LAID TWO EGGS IN A DAY. , 1907, Science.